| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.17 | 0.5 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |